Skip to main content

Published locations for Tyrosine kinase inhibitors may boost cardiac risk in chronic myeloid leukemia

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tyrosine kinase inhibitors may boost cardiac risk in chronic myeloid leukemia

User login

  • Reset your password
  • /content/tyrosine-kinase-inhibitors-may-boost-cardiac-risk-chronic-myeloid-leukemia
  • /familypracticenews/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk
  • /hematologynews/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk-chronic
  • /internalmedicinenews/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk
  • /oncologypractice/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk-chronic
  • /hematology-oncology/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk
  • /ecardiologynews/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk-chronic
  • /cardiology/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk-chronic
  • /internalmedicine/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk-chronic
  • /familymedicine/article/109614/cardiology/tyrosine-kinase-inhibitors-may-boost-cardiac-risk-chronic